Plasma microparticles from patients with systemic lupus erythematosus modulate the content of miRNAs in U937 cells
ABSTRACT: In systemic lupus erythematosus (SLE), the clearance of apoptotic cells and microparticles (MPs) is reduced. Some MPs contain molecules that can modulate immune responses. This study aimed to evaluate the presence of miR-126 and miR-146a in plasma MPs of patients with SLE (SLE MPs) and ana...
- Autores:
-
Carmona Pérez, Liseth
Rojas López, Mauricio
Muñoz Vahos, Carlos
Vanegas García, Adiana
Vásquez Duque, Gloria María
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2021
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/43707
- Acceso en línea:
- https://hdl.handle.net/10495/43707
https://onlinelibrary.wiley.com/doi/10.1111/imm.13366
- Palabra clave:
- MicroARNs
MicroRNAs
Lupus Eritematoso Sistémico
Lupus Erythematosus, Systemic
Micropartículas Derivadas de Células - Metabolismo
Cell-Derived Microparticles - Metabolism
Células U937
U937 Cells
Inmunidad
Immunity
Enfermedades Autoinmunes
Autoimmune Diseases
https://id.nlm.nih.gov/mesh/D035683
https://id.nlm.nih.gov/mesh/D008180
https://id.nlm.nih.gov/mesh/D055252
https://id.nlm.nih.gov/mesh/D020298
https://id.nlm.nih.gov/mesh/D007109
https://id.nlm.nih.gov/mesh/D001327
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
| Summary: | ABSTRACT: In systemic lupus erythematosus (SLE), the clearance of apoptotic cells and microparticles (MPs) is reduced. Some MPs contain molecules that can modulate immune responses. This study aimed to evaluate the presence of miR-126 and miR-146a in plasma MPs of patients with SLE (SLE MPs) and analyse the ability of MPs to modulate some events in the promonocytic U937 cell line. Circulating MPs were isolated from plasma samples of healthy controls (HCs), patients with SLE and other autoimmune diseases (OAD). MPs were analysed for size and cell origin by flow cytometry and content of miR-126 and miR-146a by RT-qPCR. MPs were then added to U937 cell cultures to evaluate changes in cell phenotype, cytokine expression, content of miR-126 and miR-146a, and levels of IRF5. Patients with active SLE (aSLE) showed an increase in concentration of plasma MPs that positively correlated with the SLEDAI (SLE Disease Activity Index) score. CD14+ MPs were significantly more abundant in patients with SLE than HCs. SLE MPs contained decreased levels of miR-146a, but the miR-126 content in aSLE MPs was increased. The miR-126 content in SLE MPs correlated positively with the SLEDAI score. The treatment of U937 cells with MPs from HCs and patients induced reduced expression of HLA-DR, CD18 and CD119, increased frequency of IL-6+ and TNF-α+ cells, accumulation of IL-8 in culture supernatants, increased miR-126 levels and decreased miR-146a content, but no change in the expression of IRF5. These findings suggest that plasma MPs, especially SLE MPs, could modulate some biological events in U937 cells. |
|---|
